Latest filing published 01 Nov 2017 for H-CYTE, INC., €13k.
Insider track record
James Ronald Lawson Jr.: trading record in brief
James Ronald Lawson Jr. discloses dealings in H-Cyte, Inc. to SEC (Form 4). Over a trading history stretching from 12 January 2017 to 30 October 2017, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 November 2017, reports a share grant of €13k in H-Cyte, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Ronald Lawson Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,821 shares@ US$1.1743.6% of flowCommon StockSEC:0001493152-17-012290:0
- 5,435 shares@ US$1.3856.4% of flowCommon StockSEC:0001415889-17-000096:0
2 of 2 declarations